HOME >> BIOLOGY >> NEWS
Structure of key breast cancer receptor determined

A team of scientists from Johns Hopkins and the biotechnology company Genitope has unlocked the 3-D structure of a receptor that goes awry in 20 percent to 30 percent of breast cancers. Reporting in the Feb. 13 issue of the journal Nature, the scientists also figured out how the receptor, known as HER2, interacts with an antibody, sold as Herceptin, that is used to treat thousands of breast cancer patients each year.

"Now we know exactly which building blocks of the Herceptin antibody interact with which building blocks of HER2," says Dan Leahy, Ph.D., professor of biophysics and a Howard Hughes Medical Institute investigator at the Johns Hopkins School of Medicine. "When you understand the properties of receptors and antibodies in terms of their structural interaction, you can begin to explain their effects and use the information to design better drugs."

Developed by Genentech, Herceptin kills cancer cells carrying excess HER2. But even though Herceptin was approved as a breast cancer treatment by the U.S. Food and Drug Administration in September 1998, until now no one has known precisely how it interacted with the receptor.

The findings also explain why the HER2 receptor behaves so differently from its relatives HER1, HER3 and HER4, says Leahy, in whose laboratory the structure of HER3 was deciphered last summer. While all four proteins are similar in the sequence of their building blocks, only excess HER2 leads to uncontrolled cell growth in the lab and breast cancer in people.

Like its relatives, the HER2 receptor is stuck in the cell membrane, partially outside the cell, and partially inside. The extracellular part, whose structure the scientists determined, is the receptor's "on switch." Through this region, HER receptors join into pairs to become fully active and trigger events that eventually result in cell division.

Comparisons of HER family structures reveal that a few key changes in the sequence make all th
'"/>

Contact: Joanna Downer
jdowner1@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
12-Feb-2003


Page: 1 2

Related biology news :

1. Structure solved at Scripps shows how one human protein reduces potency of chemotherapy
2. Structure solved by Scripps scientists shows one way that body controls gene expression
3. Structure of a Nobel-prize winning molecule: Aquaporin
4. Structure of HIV-neutralizing antibody solved
5. Structure of cog at the hub of metabolism reveals anti-ageing function
6. Structure of pain-modulating enzyme described by scientists at the Scripps Research Institute
7. Structure reveals details of cells cargo-carriers
8. Structure of key receptor unlocked; Related proteins will fall like dominoes
9. New Science Press launches Proteins: From Sequence to Structure
10. Third piece completes deadly puzzle: Structure of anthrax toxin offers clues to treatment
11. Structure of key protein involved in cancer, osteoporosis and foot-and-mouth disease finally solved

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/4/2019)... ... April 02, 2019 , ... ... company, will present results demonstrating that RNA genetic testing (RGT), as a supplement ... study, awarded as a Top Rated poster, is one of 13 presentations at ...
(Date:4/1/2019)... SAN FRANCISCO (PRWEB) , ... April 01, 2019 ... ... entitled “Method and System for Characterizing Skin Related Conditions” by the US Patent ... 21, 2014. The patent is an invention by uBiome collaborators Dr. Zachary ...
(Date:3/29/2019)... ... March 28, 2019 , ... In the development of biosimilars, ... a path for this task. Despite this uncertainty, several manufacturers have been successful and ... the first part of this webinar, learn how analytical similarity is achieved in biosimilars ...
Breaking Biology News(10 mins):
(Date:4/4/2019)... ... April 02, 2019 , ... Biomeme, Inc. , ... it’s latest field-ready solution for performing PCR, RT-PCR, qPCR, and Isothermal tests called ... to Rosland Franklin, an English chemist and X-ray crystallographer who made significant contributions ...
(Date:3/27/2019)... ... , ... Lachman is sponsoring the event on April 1-4, where they will ... executive team on site will be available to discuss strategies and tactics to support ... year. , Executives from Lachman participating at this year’s conference include Fran Zipp, President ...
(Date:3/19/2019)... Calif. (PRWEB) , ... March 19, 2019 , ... Bogey was nine years old when ... arthritis in his left hip. These ailments caused Bogey to experience problems with his ... vehicles, up stairs, and onto his special spot on the couch. , His owners, devastated ...
(Date:3/18/2019)... ... March 18, 2019 , ... For more than 15 years, USDM Life ... life science companies to easily comply with FDA 21 CFR Part 11 and EMA ... managed service delivering end-to-end GxP compliance from vendor audit through ongoing validation maintenance, including ...
Breaking Biology Technology:
Cached News: